| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NTLA | Common Stock | Sale | $5,433 | -105 | -0.65% | $51.74 | 16,165 | 01 Jul 2022 | Direct | F1 |
| transaction | NTLA | Common Stock | Sale | $7,965 | -231 | -1.4% | $34.48 | 16,165 | 03 Jan 2023 | Direct | F2 |
| transaction | NTLA | Common Stock | Sale | $62,959 | -1,692 | -10% | $37.21 | 14,473 | 04 Jan 2023 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Sale of 105 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2022. |
| F2 | Sale of 231 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on December 31, 2022. |
| F3 | Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on January 1, 2023. |